Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), filed a Form 4 on October 29, 2026, disclosing the exercise and sale of common shares across three consecutive trading days, October 27 through October 29, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Three-day exercise and sale: Mahboob exercised options and sold shares on October 27, 28, and 29, 2026, disposing of 34,809, 39,903, and 4,788 common shares, respectively.
  • Exercise price: All options were exercised at $17 per share.
  • Weighted average sale prices: Shares sold at weighted average prices of $30.0435 on October 27, $30.4815 on October 28, and $30.5979 on October 29.
  • Remaining beneficial ownership: Following all reported transactions, Mahboob directly owns 60,609 common shares.
  • Remaining options: After the three-day exercises, 79,500 options with an exercise price of $17 and expiration date of March 6, 2035, remain beneficially owned.
  • 10b5-1 plan: All transactions were made pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025.

Kestra Medical CFO Option Exercises and Share Sales: October 27-29, 2026

According to the filing, Vaseem Mahboob, Chief Financial Officer of Kestra Medical Technologies, Ltd., exercised stock options and sold the resulting common shares over three consecutive days under a pre-established Rule 10b5-1 trading plan adopted on November 5, 2025. On October 27, he exercised 34,809 options at $17 per share and sold 34,809 shares at a weighted average price of $30.0435, with individual sale prices ranging from $30.0000 to $30.4300.

On October 28, Mahboob exercised an additional 39,903 options at $17 per share and sold 39,903 shares at a weighted average price of $30.4815, with individual prices ranging from $30.0100 to $30.9800. On October 29, he exercised 4,788 options at $17 per share and sold 4,788 shares at a weighted average price of $30.5979, with individual prices ranging from $30.3500 to $31.0400. The filing notes that weighted average prices are reported and that Mahboob will provide the number of shares sold at each price within these ranges upon request to the issuer, any security holder, or SEC staff.

Following the three reported transactions, Mahboob directly holds 60,609 common shares. His remaining options position stands at 79,500 options with an exercise price of $17 and an expiration date of March 6, 2035. The filing indicates that as of the filing date, 46,375 of those options are fully vested, with the remaining 33,125 vesting in equal monthly installments through March 6, 2027. The Form 4 was signed by Traci S. Umberger as attorney-in-fact for Vaseem Mahboob on October 29, 2026.

What Was Disclosed

Kestra Medical Technologies CFO Vaseem Mahboob disclosed option exercises totaling 79,500 shares and corresponding open-market sales of 79,500 common shares over October 27-29, 2026, under a pre-existing 10b5-1 plan, leaving him with direct ownership of 60,609 common shares.